Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
Bay 43-9006 or a combination of both give similar results in terms of measurement of external tumor size (around 58% growth reduction compare with control tumors)
20-heptamethyl-11-oxido-9-oxodocosa-10
InChi: InChI=1S/C23H16F3N3O6/c1-27-17-7-5-11(9-18(17)35-22(27)34)28-10-14(20(31)32)19(30)29(21(28)33)16-8-6-12-13(16)3-2-4-15(12)23(24
Kaniskan HÜ
selective and orally available PORCN inhibitor
PF-04217903 Size:2mg solid Bay 43-9006 or a combinationPF 04217903 is a MET tyrosine kinase inhibitor, is also a n orally bioavailabe, small molecule tyrosine kinase inhibitor of the proto oncogene c Met (hepatocyte growth factor receptor [HGFR]) with potential antineoplastic activity. c Met inhibitor PF 04217903 selectively binds to and inhibits c Met, disrupting the c Met signaling pathway, which may result in the inhibition of tumor cell growth, migration and invasion of tumor cells, and the induction
US$ 137.50
US$ 4575.00
US$ 1621.50
US$ 5149.50